Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
Returns on capital
Odyssey Therapeutics, Inc. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
No return metrics data available.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Jason Haas | Chief Financial Officer | USD 702.5K | 58 | — | — |
Gary D. Glick | Founder, President, CEO & Director | USD 558.9K | 64 | — | — |
Collin Todd | Senior Vice President of Strategy & Business Development | USD 544.9K | 34 | — | — |
Eicke Latz | Scientific Co-Founder | — | — | — | — |
Jolie Siegel | Executive VP, General Counsel & Secretary | — | 49 | — | — |
Joseph McDonald | Chief Data Officer | — | — | — | — |
Natalie Dales | Chief of Research Operations & Portfolio Strategy | — | 56 | — | — |
Felix Meissner | Scientific Co-Founder | — | — | — | — |
Florian.I Schmidt | Scientific Co-Founder | — | — | — | — |
Kim Lewis | Scientific Co-Founder | — | — | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
No open-market purchases or sales in the last 12 months.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
Competitors
Who does Odyssey Therapeutics, Inc. compete with?
Open similar companies to compare how their management teams allocate capital.
Questions
Management questions
Common questions about ODTX's management, answered from reported figures.
Who manages ODTX?
Odyssey Therapeutics, Inc. (ODTX) lists 10 active executives. The top listed executive is Eicke Latz, Scientific Co-Founder.
Continue the stock analysis
Jump to another research area for this company.